• A co-occurrence of osteogenesis imperfecta type VI and cystinosis
• A mouse model for human osteogenesis imperfecta type VI
• A new culprit in osteogenesis imperfecta
• A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor
• Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta
• Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta
• Anesthetic Management Including Postoperative Regional Anesthesia in a Young Adult Patient With Von Willebrand Disease and Osteogenesis Imperfecta
• Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis
• Bone allografting: an original method for biological osteosynthesis and bone reinforcement in children with osteogenesis imperfecta
• Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses
• Deep intronic mutation in CRTAP results in unstable isoforms of the protein to induce type I collagen aggregation in a lethal type of osteogenesis imperfecta type VII
• Delivering a Home-Based Exercise Program to Youth With Osteogenesis Imperfecta: Protocol for a Comparative-Approach Study
• Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review
• First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI
• Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta
• Hereditary dentin defects with systemic diseases
• Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI
• Keratoconus tomographic indices in osteogenesis imperfecta
• Osteogenesis Imperfecta Type VI in Individuals from Northern Canada
• Osteogenesis imperfecta, an ever-expanding conundrum
• Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients
• Pulmonary function and structure abnormalities in children and young adults with osteogenesis imperfecta point to intrinsic and extrinsic lung abnormalities
• Respiratory function of children and adolescents with osteogenesis imperfecta: respiratory muscle strength, forced vital capacity, and peak expiratory flow
• Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice
• Skeletal muscle mitochondrial function and whole-body metabolic energetics in the +/G610C mouse model of osteogenesis imperfecta
• The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI
• Treatment response to long term antiresorptive therapy in osteogenesis imperfecta type VI: does genotype matter?
• Two years' experience with denosumab for children with osteogenesis imperfecta type VI
• Unequal Impact of <em>COL1A1</em> and <em>COL1A2</em> Variants on Dentinogenesis Imperfecta
• Which is the best femoral implant in children with osteogenesis imperfecta? a retrospective cohort study of 783 procedures